Publication Name	World Journal of Clinical Cases
Manuscript ID	60360
Country	China

Category	Oncology
Manuscript Type	Case Report
Article Title	Primary mesonephric adenocarcinoma of fallopian tube: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Chuan Xie, Yang-Mei Shen, Qiu-He Chen and Ce Bian
Funding Agency and Grant Number
Corresponding Author	Ce Bian, MD, PhD, N/A, Department of Gynecology and Obstetrics, West China Second University Hospital, No. 20 Section Three, South Renmin Road, Chengdu 610041, Sichuan Province, China. terrybian@163.com
Key Words	Mesonephric adenocarcinoma; Mesonephric-like adenocarcinoma; Fallopian tube; Surgery; Chemotherapy; Case report
Core Tip	We presented the first case of primary mesonephric adenocarcinoma (MNAC) deriving from fallopian tube without sign of relapse or metastasis after second excision of recurrent lesions until now, which demonstrated a satisfactory response to combination chemotherapy of gemcitabine and carboplatin. MNAC originating from fallopian tube can be very aggressive, even when early stage. Because of its sensitivity to the chemotherapy regimen, it is reasonable that combination chemotherapy of gemcitabine and carboplatin plays an important role in treatment of recurrent MNAC deriving from fallopian tube. However, further research is needed to determine the effectiveness of this chemotherapy regimen and provide better therapeutic regimen.
Citation	Xie C, Shen YM, Chen QH, Bian C. Primary mesonephric adenocarcinoma of fallopian tube: A case report. World J Clin Cases 2021; 9(18): 4741-4747

Received	2020-10-30 11:47
Peer-Review Started	2020-10-27 03:13
To Make the First Decision
Return for Revision	2021-01-17 18:33
Revised	2021-04-21 11:53
Second Decision	2021-04-29 05:48
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-04-29 11:20
Articles in Press	2021-04-29 11:20
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-05-05 11:23
Typeset the Manuscript	2021-06-07 08:54

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com